[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100109104":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":22,"locations":27,"responsibleParty":43,"collaborators":10,"id":45,"slug":10,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":10,"eligibilityCriteria":49,"healthyVolunteers":46,"sex":50,"minAge":10,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"St. Jude Children's Research Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational Group",null,"Data Collection",[13],"Other: Data Collection",[15],{"type":6,"name":11,"description":16,"armGroupLabels":17,"otherNames":10},"Continuing review of outcomes and late toxicities",[9],[19],{"name":20,"affiliation":5,"role":21},"Melissa M Hudson, MD","PRINCIPAL_INVESTIGATOR",[23],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","888-226-4343","referralinfo@stjude.org",[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Memphis","Tennessee","38105","United States",{"type":35,"coordinates":36},"Point",[37,38],-90.04898,35.14953,{"lat":38,"lon":37},[41,42],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},{"name":20,"role":21,"phone":10,"phoneExt":10,"email":10},{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100109104",false,"NCT00684580","Protocol For Collecting Data On Patients With Childhood Cancer","Inclusion Criteria:\n\n* All St Jude patients actively being followed or treated for childhood cancer\n\nExclusion Criteria:\n\n* St. Jude consult only patients\n* St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice.\n* Patients referred to St. Jude for limited care on phase 1 protocol.","ALL",{"count":52,"type":53},30000,"ESTIMATED","OBSERVATIONAL","Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.",[57],"Childhood Cancer",[59,60],"St. Jude Alumni","St. Jude Life Participants","2026-06-15",{"date":63,"type":64},"2026-06-17","ACTUAL",{"date":66,"type":64},"2000-06-08",{"date":68,"type":53},"2045-05",{"name":5,"class":6},1]